In an op-ed in Roll Call, GHTC Director Kaitlin Christenson and former Congressman Michael Castle (R-DE) reflect on the progress achieved in global health product development as a result of US investment and innovative product development partnerships, and warn that budget cuts could put this momentum at risk.
In the final article in a five-part blog series to coincide with the release of GHTC's policy report, the Global Health Council's blog interviews Seth Berkley, founder of the International AIDS Vaccine Initiative and CEO-elect of GAVI, the vaccine alliance, about progress in HIV vaccine research and the critical role of US investment.
In the fourth article in a five-part blog series to coincide with the release of GHTC's policy report, Global Health Council's blog interviews Dr. Roma Chilengi, head of clinical trials at the Kenya Medical Research Institute, to discuss the role of partnerships in advancing clinical trials of critically needed health technologies.
In the third article in a five-part blog series to coincide with the release of GHTC's policy report, the Global Health Council blog interviews Nelson Michael, Director of the US Military HIV Research Program, about the US military's work in R&D for tools to combat infectious diseases, including the military's involvement in developing an HIV vaccine candidate.